nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00162	0.00245	CcSEcCtD
Rasagiline—Myocardial infarction—Pravastatin—atherosclerosis	0.00161	0.00243	CcSEcCtD
Rasagiline—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00161	0.00243	CcSEcCtD
Rasagiline—Jaundice—Pravastatin—atherosclerosis	0.0016	0.00242	CcSEcCtD
Rasagiline—Sweating—Niacin—atherosclerosis	0.0016	0.00242	CcSEcCtD
Rasagiline—Chills—Lovastatin—atherosclerosis	0.00156	0.00236	CcSEcCtD
Rasagiline—Cough—Rosuvastatin—atherosclerosis	0.00156	0.00236	CcSEcCtD
Rasagiline—Angiopathy—Ezetimibe—atherosclerosis	0.00155	0.00235	CcSEcCtD
Rasagiline—Immune system disorder—Ezetimibe—atherosclerosis	0.00154	0.00233	CcSEcCtD
Rasagiline—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00154	0.00233	CcSEcCtD
Rasagiline—Alopecia—Lovastatin—atherosclerosis	0.00154	0.00233	CcSEcCtD
Rasagiline—Arthralgia—Rosuvastatin—atherosclerosis	0.00152	0.0023	CcSEcCtD
Rasagiline—Alopecia—Ezetimibe—atherosclerosis	0.00151	0.00228	CcSEcCtD
Rasagiline—Haemoglobin—Niacin—atherosclerosis	0.0015	0.00227	CcSEcCtD
Rasagiline—Rhinitis—Niacin—atherosclerosis	0.0015	0.00227	CcSEcCtD
Rasagiline—Mental disorder—Ezetimibe—atherosclerosis	0.0015	0.00226	CcSEcCtD
Rasagiline—Haemorrhage—Niacin—atherosclerosis	0.0015	0.00226	CcSEcCtD
Rasagiline—Flatulence—Lovastatin—atherosclerosis	0.00149	0.00226	CcSEcCtD
Rasagiline—Hypoaesthesia—Niacin—atherosclerosis	0.00149	0.00225	CcSEcCtD
Rasagiline—Malnutrition—Ezetimibe—atherosclerosis	0.00149	0.00225	CcSEcCtD
Rasagiline—Dysgeusia—Lovastatin—atherosclerosis	0.00148	0.00225	CcSEcCtD
Rasagiline—Rhinitis—Pravastatin—atherosclerosis	0.00148	0.00223	CcSEcCtD
Rasagiline—Oedema peripheral—Niacin—atherosclerosis	0.00147	0.00223	CcSEcCtD
Rasagiline—Confusional state—Rosuvastatin—atherosclerosis	0.00147	0.00223	CcSEcCtD
Rasagiline—Back pain—Lovastatin—atherosclerosis	0.00147	0.00222	CcSEcCtD
Rasagiline—Hypoaesthesia—Pravastatin—atherosclerosis	0.00146	0.00222	CcSEcCtD
Rasagiline—Flatulence—Ezetimibe—atherosclerosis	0.00146	0.00222	CcSEcCtD
Rasagiline—Chills—Simvastatin—atherosclerosis	0.00146	0.00221	CcSEcCtD
Rasagiline—Muscle spasms—Lovastatin—atherosclerosis	0.00146	0.00221	CcSEcCtD
Rasagiline—Infection—Rosuvastatin—atherosclerosis	0.00145	0.00219	CcSEcCtD
Rasagiline—Alopecia—Simvastatin—atherosclerosis	0.00144	0.00218	CcSEcCtD
Rasagiline—Back pain—Ezetimibe—atherosclerosis	0.00144	0.00218	CcSEcCtD
Rasagiline—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00143	0.00217	CcSEcCtD
Rasagiline—Muscle spasms—Ezetimibe—atherosclerosis	0.00143	0.00216	CcSEcCtD
Rasagiline—Mental disorder—Simvastatin—atherosclerosis	0.00143	0.00216	CcSEcCtD
Rasagiline—Tremor—Lovastatin—atherosclerosis	0.00142	0.00215	CcSEcCtD
Rasagiline—Ill-defined disorder—Lovastatin—atherosclerosis	0.00141	0.00213	CcSEcCtD
Rasagiline—Eye disorder—Niacin—atherosclerosis	0.0014	0.00212	CcSEcCtD
Rasagiline—Flatulence—Simvastatin—atherosclerosis	0.0014	0.00211	CcSEcCtD
Rasagiline—Dysgeusia—Simvastatin—atherosclerosis	0.00139	0.0021	CcSEcCtD
Rasagiline—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00138	0.00209	CcSEcCtD
Rasagiline—Anaemia—Ezetimibe—atherosclerosis	0.00137	0.00208	CcSEcCtD
Rasagiline—Malaise—Lovastatin—atherosclerosis	0.00137	0.00207	CcSEcCtD
Rasagiline—Cardiac disorder—Pravastatin—atherosclerosis	0.00137	0.00207	CcSEcCtD
Rasagiline—Muscle spasms—Simvastatin—atherosclerosis	0.00136	0.00206	CcSEcCtD
Rasagiline—Vertigo—Lovastatin—atherosclerosis	0.00136	0.00206	CcSEcCtD
Rasagiline—Angiopathy—Niacin—atherosclerosis	0.00136	0.00205	CcSEcCtD
Rasagiline—Leukopenia—Lovastatin—atherosclerosis	0.00136	0.00205	CcSEcCtD
Rasagiline—Chills—Niacin—atherosclerosis	0.00134	0.00203	CcSEcCtD
Rasagiline—Malaise—Ezetimibe—atherosclerosis	0.00134	0.00203	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00133	0.00201	CcSEcCtD
Rasagiline—Tremor—Simvastatin—atherosclerosis	0.00133	0.00201	CcSEcCtD
Rasagiline—Alopecia—Niacin—atherosclerosis	0.00132	0.002	CcSEcCtD
Rasagiline—Chills—Pravastatin—atherosclerosis	0.00132	0.002	CcSEcCtD
Rasagiline—Insomnia—Rosuvastatin—atherosclerosis	0.00132	0.002	CcSEcCtD
Rasagiline—Ill-defined disorder—Simvastatin—atherosclerosis	0.00132	0.00199	CcSEcCtD
Rasagiline—Paraesthesia—Rosuvastatin—atherosclerosis	0.00131	0.00198	CcSEcCtD
Rasagiline—Anaemia—Simvastatin—atherosclerosis	0.00131	0.00198	CcSEcCtD
Rasagiline—Malnutrition—Niacin—atherosclerosis	0.0013	0.00197	CcSEcCtD
Rasagiline—Alopecia—Pravastatin—atherosclerosis	0.0013	0.00197	CcSEcCtD
Rasagiline—Cough—Ezetimibe—atherosclerosis	0.0013	0.00196	CcSEcCtD
Rasagiline—Chest pain—Lovastatin—atherosclerosis	0.00129	0.00195	CcSEcCtD
Rasagiline—Arthralgia—Lovastatin—atherosclerosis	0.00129	0.00195	CcSEcCtD
Rasagiline—Anxiety—Lovastatin—atherosclerosis	0.00129	0.00195	CcSEcCtD
Rasagiline—Dyspepsia—Rosuvastatin—atherosclerosis	0.00128	0.00194	CcSEcCtD
Rasagiline—Hypertension—Ezetimibe—atherosclerosis	0.00128	0.00194	CcSEcCtD
Rasagiline—Flatulence—Niacin—atherosclerosis	0.00128	0.00194	CcSEcCtD
Rasagiline—Malaise—Simvastatin—atherosclerosis	0.00128	0.00194	CcSEcCtD
Rasagiline—Discomfort—Lovastatin—atherosclerosis	0.00127	0.00193	CcSEcCtD
Rasagiline—Vertigo—Simvastatin—atherosclerosis	0.00127	0.00193	CcSEcCtD
Rasagiline—Leukopenia—Simvastatin—atherosclerosis	0.00127	0.00192	CcSEcCtD
Rasagiline—Arthralgia—Ezetimibe—atherosclerosis	0.00127	0.00192	CcSEcCtD
Rasagiline—Chest pain—Ezetimibe—atherosclerosis	0.00127	0.00192	CcSEcCtD
Rasagiline—Flatulence—Pravastatin—atherosclerosis	0.00126	0.00191	CcSEcCtD
Rasagiline—Dry mouth—Lovastatin—atherosclerosis	0.00126	0.00191	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00126	0.0019	CcSEcCtD
Rasagiline—Dysgeusia—Pravastatin—atherosclerosis	0.00126	0.0019	CcSEcCtD
Rasagiline—Muscle spasms—Niacin—atherosclerosis	0.00125	0.00189	CcSEcCtD
Rasagiline—Discomfort—Ezetimibe—atherosclerosis	0.00125	0.00189	CcSEcCtD
Rasagiline—Constipation—Rosuvastatin—atherosclerosis	0.00125	0.00189	CcSEcCtD
Rasagiline—Confusional state—Lovastatin—atherosclerosis	0.00125	0.00189	CcSEcCtD
Rasagiline—Dry mouth—Ezetimibe—atherosclerosis	0.00124	0.00187	CcSEcCtD
Rasagiline—Muscle spasms—Pravastatin—atherosclerosis	0.00123	0.00187	CcSEcCtD
Rasagiline—Infection—Lovastatin—atherosclerosis	0.00123	0.00186	CcSEcCtD
Rasagiline—Confusional state—Ezetimibe—atherosclerosis	0.00122	0.00185	CcSEcCtD
Rasagiline—Arthralgia—Simvastatin—atherosclerosis	0.00121	0.00183	CcSEcCtD
Rasagiline—Chest pain—Simvastatin—atherosclerosis	0.00121	0.00183	CcSEcCtD
Rasagiline—Infection—Ezetimibe—atherosclerosis	0.00121	0.00182	CcSEcCtD
Rasagiline—Feeling abnormal—Rosuvastatin—atherosclerosis	0.0012	0.00182	CcSEcCtD
Rasagiline—Anxiety—Simvastatin—atherosclerosis	0.0012	0.00182	CcSEcCtD
Rasagiline—Tremor—Pravastatin—atherosclerosis	0.0012	0.00182	CcSEcCtD
Rasagiline—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00119	0.00181	CcSEcCtD
Rasagiline—Discomfort—Simvastatin—atherosclerosis	0.00119	0.00181	CcSEcCtD
Rasagiline—Nervous system disorder—Ezetimibe—atherosclerosis	0.00119	0.0018	CcSEcCtD
Rasagiline—Ill-defined disorder—Pravastatin—atherosclerosis	0.00119	0.0018	CcSEcCtD
Rasagiline—Anaemia—Pravastatin—atherosclerosis	0.00118	0.00179	CcSEcCtD
Rasagiline—Anorexia—Lovastatin—atherosclerosis	0.00118	0.00178	CcSEcCtD
Rasagiline—Skin disorder—Ezetimibe—atherosclerosis	0.00118	0.00178	CcSEcCtD
Rasagiline—Vertigo—Niacin—atherosclerosis	0.00117	0.00177	CcSEcCtD
Rasagiline—Syncope—Niacin—atherosclerosis	0.00117	0.00177	CcSEcCtD
Rasagiline—Confusional state—Simvastatin—atherosclerosis	0.00117	0.00177	CcSEcCtD
Rasagiline—Leukopenia—Niacin—atherosclerosis	0.00117	0.00176	CcSEcCtD
Rasagiline—Urticaria—Rosuvastatin—atherosclerosis	0.00116	0.00176	CcSEcCtD
Rasagiline—Malaise—Pravastatin—atherosclerosis	0.00116	0.00175	CcSEcCtD
Rasagiline—Abdominal pain—Rosuvastatin—atherosclerosis	0.00115	0.00175	CcSEcCtD
Rasagiline—Vertigo—Pravastatin—atherosclerosis	0.00115	0.00174	CcSEcCtD
Rasagiline—Infection—Simvastatin—atherosclerosis	0.00115	0.00174	CcSEcCtD
Rasagiline—Leukopenia—Pravastatin—atherosclerosis	0.00115	0.00174	CcSEcCtD
Rasagiline—Loss of consciousness—Niacin—atherosclerosis	0.00114	0.00173	CcSEcCtD
Rasagiline—Cough—Niacin—atherosclerosis	0.00114	0.00172	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00113	0.00171	CcSEcCtD
Rasagiline—Insomnia—Lovastatin—atherosclerosis	0.00112	0.00169	CcSEcCtD
Rasagiline—Cough—Pravastatin—atherosclerosis	0.00112	0.00169	CcSEcCtD
Rasagiline—Paraesthesia—Lovastatin—atherosclerosis	0.00111	0.00168	CcSEcCtD
Rasagiline—Arthralgia—Niacin—atherosclerosis	0.00111	0.00168	CcSEcCtD
Rasagiline—Hypertension—Pravastatin—atherosclerosis	0.00111	0.00167	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00111	0.00167	CcSEcCtD
Rasagiline—Anorexia—Simvastatin—atherosclerosis	0.0011	0.00167	CcSEcCtD
Rasagiline—Dyspnoea—Lovastatin—atherosclerosis	0.0011	0.00167	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.0011	0.00167	CcSEcCtD
Rasagiline—Insomnia—Ezetimibe—atherosclerosis	0.0011	0.00166	CcSEcCtD
Rasagiline—Arthralgia—Pravastatin—atherosclerosis	0.00109	0.00165	CcSEcCtD
Rasagiline—Chest pain—Pravastatin—atherosclerosis	0.00109	0.00165	CcSEcCtD
Rasagiline—Paraesthesia—Ezetimibe—atherosclerosis	0.00109	0.00165	CcSEcCtD
Rasagiline—Dyspepsia—Lovastatin—atherosclerosis	0.00109	0.00165	CcSEcCtD
Rasagiline—Anxiety—Pravastatin—atherosclerosis	0.00109	0.00165	CcSEcCtD
Rasagiline—Dry mouth—Niacin—atherosclerosis	0.00108	0.00164	CcSEcCtD
Rasagiline—Dyspnoea—Ezetimibe—atherosclerosis	0.00108	0.00164	CcSEcCtD
Rasagiline—Discomfort—Pravastatin—atherosclerosis	0.00108	0.00163	CcSEcCtD
Rasagiline—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00108	0.00163	CcSEcCtD
Rasagiline—Decreased appetite—Lovastatin—atherosclerosis	0.00108	0.00163	CcSEcCtD
Rasagiline—Dyspepsia—Ezetimibe—atherosclerosis	0.00107	0.00162	CcSEcCtD
Rasagiline—Constipation—Lovastatin—atherosclerosis	0.00106	0.0016	CcSEcCtD
Rasagiline—Confusional state—Pravastatin—atherosclerosis	0.00105	0.0016	CcSEcCtD
Rasagiline—Decreased appetite—Ezetimibe—atherosclerosis	0.00105	0.0016	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00105	0.0016	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00105	0.00159	CcSEcCtD
Rasagiline—Asthenia—Rosuvastatin—atherosclerosis	0.00105	0.00159	CcSEcCtD
Rasagiline—Insomnia—Simvastatin—atherosclerosis	0.00105	0.00158	CcSEcCtD
Rasagiline—Shock—Niacin—atherosclerosis	0.00105	0.00158	CcSEcCtD
Rasagiline—Infection—Pravastatin—atherosclerosis	0.00104	0.00157	CcSEcCtD
Rasagiline—Paraesthesia—Simvastatin—atherosclerosis	0.00104	0.00157	CcSEcCtD
Rasagiline—Constipation—Ezetimibe—atherosclerosis	0.00104	0.00157	CcSEcCtD
Rasagiline—Pruritus—Rosuvastatin—atherosclerosis	0.00103	0.00156	CcSEcCtD
Rasagiline—Skin disorder—Niacin—atherosclerosis	0.00103	0.00156	CcSEcCtD
Rasagiline—Dyspnoea—Simvastatin—atherosclerosis	0.00103	0.00156	CcSEcCtD
Rasagiline—Hyperhidrosis—Niacin—atherosclerosis	0.00103	0.00155	CcSEcCtD
Rasagiline—Feeling abnormal—Lovastatin—atherosclerosis	0.00102	0.00154	CcSEcCtD
Rasagiline—Dyspepsia—Simvastatin—atherosclerosis	0.00102	0.00154	CcSEcCtD
Rasagiline—Anorexia—Niacin—atherosclerosis	0.00101	0.00153	CcSEcCtD
Rasagiline—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00101	0.00153	CcSEcCtD
Rasagiline—Hyperhidrosis—Pravastatin—atherosclerosis	0.00101	0.00153	CcSEcCtD
Rasagiline—Decreased appetite—Simvastatin—atherosclerosis	0.00101	0.00152	CcSEcCtD
Rasagiline—Feeling abnormal—Ezetimibe—atherosclerosis	0.001	0.00151	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000999	0.00151	CcSEcCtD
Rasagiline—Diarrhoea—Rosuvastatin—atherosclerosis	0.000999	0.00151	CcSEcCtD
Rasagiline—Anorexia—Pravastatin—atherosclerosis	0.000997	0.00151	CcSEcCtD
Rasagiline—Hypotension—Niacin—atherosclerosis	0.000993	0.0015	CcSEcCtD
Rasagiline—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000992	0.0015	CcSEcCtD
Rasagiline—Constipation—Simvastatin—atherosclerosis	0.000989	0.0015	CcSEcCtD
Rasagiline—Urticaria—Lovastatin—atherosclerosis	0.000983	0.00149	CcSEcCtD
Rasagiline—Abdominal pain—Lovastatin—atherosclerosis	0.000978	0.00148	CcSEcCtD
Rasagiline—Body temperature increased—Lovastatin—atherosclerosis	0.000978	0.00148	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000968	0.00147	CcSEcCtD
Rasagiline—Dizziness—Rosuvastatin—atherosclerosis	0.000965	0.00146	CcSEcCtD
Rasagiline—Urticaria—Ezetimibe—atherosclerosis	0.000964	0.00146	CcSEcCtD
Rasagiline—Insomnia—Niacin—atherosclerosis	0.000961	0.00145	CcSEcCtD
Rasagiline—Body temperature increased—Ezetimibe—atherosclerosis	0.000959	0.00145	CcSEcCtD
Rasagiline—Abdominal pain—Ezetimibe—atherosclerosis	0.000959	0.00145	CcSEcCtD
Rasagiline—Paraesthesia—Niacin—atherosclerosis	0.000954	0.00144	CcSEcCtD
Rasagiline—Feeling abnormal—Simvastatin—atherosclerosis	0.000953	0.00144	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000953	0.00144	CcSEcCtD
Rasagiline—Dyspnoea—Niacin—atherosclerosis	0.000947	0.00143	CcSEcCtD
Rasagiline—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000946	0.00143	CcSEcCtD
Rasagiline—Insomnia—Pravastatin—atherosclerosis	0.000946	0.00143	CcSEcCtD
Rasagiline—Somnolence—Niacin—atherosclerosis	0.000944	0.00143	CcSEcCtD
Rasagiline—Paraesthesia—Pravastatin—atherosclerosis	0.000939	0.00142	CcSEcCtD
Rasagiline—Dyspepsia—Niacin—atherosclerosis	0.000935	0.00142	CcSEcCtD
Rasagiline—Dyspnoea—Pravastatin—atherosclerosis	0.000933	0.00141	CcSEcCtD
Rasagiline—Decreased appetite—Niacin—atherosclerosis	0.000924	0.0014	CcSEcCtD
Rasagiline—Dyspepsia—Pravastatin—atherosclerosis	0.000921	0.00139	CcSEcCtD
Rasagiline—Rash—Rosuvastatin—atherosclerosis	0.00092	0.00139	CcSEcCtD
Rasagiline—Dermatitis—Rosuvastatin—atherosclerosis	0.000919	0.00139	CcSEcCtD
Rasagiline—Urticaria—Simvastatin—atherosclerosis	0.000919	0.00139	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Niacin—atherosclerosis	0.000917	0.00139	CcSEcCtD
Rasagiline—Body temperature increased—Simvastatin—atherosclerosis	0.000915	0.00138	CcSEcCtD
Rasagiline—Abdominal pain—Simvastatin—atherosclerosis	0.000915	0.00138	CcSEcCtD
Rasagiline—Headache—Rosuvastatin—atherosclerosis	0.000914	0.00138	CcSEcCtD
Rasagiline—Hypersensitivity—Lovastatin—atherosclerosis	0.000911	0.00138	CcSEcCtD
Rasagiline—Decreased appetite—Pravastatin—atherosclerosis	0.000909	0.00138	CcSEcCtD
Rasagiline—Constipation—Pravastatin—atherosclerosis	0.000895	0.00135	CcSEcCtD
Rasagiline—Hypersensitivity—Ezetimibe—atherosclerosis	0.000894	0.00135	CcSEcCtD
Rasagiline—Asthenia—Lovastatin—atherosclerosis	0.000888	0.00134	CcSEcCtD
Rasagiline—Pruritus—Lovastatin—atherosclerosis	0.000875	0.00132	CcSEcCtD
Rasagiline—Asthenia—Ezetimibe—atherosclerosis	0.00087	0.00132	CcSEcCtD
Rasagiline—Gastrointestinal pain—Niacin—atherosclerosis	0.000869	0.00131	CcSEcCtD
Rasagiline—Nausea—Rosuvastatin—atherosclerosis	0.000867	0.00131	CcSEcCtD
Rasagiline—Feeling abnormal—Pravastatin—atherosclerosis	0.000862	0.0013	CcSEcCtD
Rasagiline—Pruritus—Ezetimibe—atherosclerosis	0.000858	0.0013	CcSEcCtD
Rasagiline—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000855	0.00129	CcSEcCtD
Rasagiline—Hypersensitivity—Simvastatin—atherosclerosis	0.000852	0.00129	CcSEcCtD
Rasagiline—Diarrhoea—Lovastatin—atherosclerosis	0.000846	0.00128	CcSEcCtD
Rasagiline—Urticaria—Niacin—atherosclerosis	0.000844	0.00128	CcSEcCtD
Rasagiline—Body temperature increased—Niacin—atherosclerosis	0.00084	0.00127	CcSEcCtD
Rasagiline—Abdominal pain—Niacin—atherosclerosis	0.00084	0.00127	CcSEcCtD
Rasagiline—Urticaria—Pravastatin—atherosclerosis	0.000831	0.00126	CcSEcCtD
Rasagiline—Asthenia—Simvastatin—atherosclerosis	0.00083	0.00126	CcSEcCtD
Rasagiline—Diarrhoea—Ezetimibe—atherosclerosis	0.00083	0.00126	CcSEcCtD
Rasagiline—Abdominal pain—Pravastatin—atherosclerosis	0.000827	0.00125	CcSEcCtD
Rasagiline—Body temperature increased—Pravastatin—atherosclerosis	0.000827	0.00125	CcSEcCtD
Rasagiline—Pruritus—Simvastatin—atherosclerosis	0.000819	0.00124	CcSEcCtD
Rasagiline—Dizziness—Lovastatin—atherosclerosis	0.000818	0.00124	CcSEcCtD
Rasagiline—Dizziness—Ezetimibe—atherosclerosis	0.000802	0.00121	CcSEcCtD
Rasagiline—Diarrhoea—Simvastatin—atherosclerosis	0.000792	0.0012	CcSEcCtD
Rasagiline—Vomiting—Lovastatin—atherosclerosis	0.000786	0.00119	CcSEcCtD
Rasagiline—Hypersensitivity—Niacin—atherosclerosis	0.000783	0.00118	CcSEcCtD
Rasagiline—Rash—Lovastatin—atherosclerosis	0.00078	0.00118	CcSEcCtD
Rasagiline—Dermatitis—Lovastatin—atherosclerosis	0.000779	0.00118	CcSEcCtD
Rasagiline—Headache—Lovastatin—atherosclerosis	0.000775	0.00117	CcSEcCtD
Rasagiline—Vomiting—Ezetimibe—atherosclerosis	0.000771	0.00117	CcSEcCtD
Rasagiline—Hypersensitivity—Pravastatin—atherosclerosis	0.000771	0.00117	CcSEcCtD
Rasagiline—Dizziness—Simvastatin—atherosclerosis	0.000765	0.00116	CcSEcCtD
Rasagiline—Rash—Ezetimibe—atherosclerosis	0.000765	0.00116	CcSEcCtD
Rasagiline—Dermatitis—Ezetimibe—atherosclerosis	0.000764	0.00116	CcSEcCtD
Rasagiline—Asthenia—Niacin—atherosclerosis	0.000762	0.00115	CcSEcCtD
Rasagiline—Headache—Ezetimibe—atherosclerosis	0.00076	0.00115	CcSEcCtD
Rasagiline—Pruritus—Niacin—atherosclerosis	0.000752	0.00114	CcSEcCtD
Rasagiline—Asthenia—Pravastatin—atherosclerosis	0.000751	0.00114	CcSEcCtD
Rasagiline—Pruritus—Pravastatin—atherosclerosis	0.00074	0.00112	CcSEcCtD
Rasagiline—BCL2—Integrated Cancer Pathway—AKT1—atherosclerosis	0.000737	0.00217	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—AKT1—atherosclerosis	0.000737	0.00217	CbGpPWpGaD
Rasagiline—Vomiting—Simvastatin—atherosclerosis	0.000736	0.00111	CcSEcCtD
Rasagiline—Nausea—Lovastatin—atherosclerosis	0.000735	0.00111	CcSEcCtD
Rasagiline—Rash—Simvastatin—atherosclerosis	0.00073	0.0011	CcSEcCtD
Rasagiline—Dermatitis—Simvastatin—atherosclerosis	0.000729	0.0011	CcSEcCtD
Rasagiline—Diarrhoea—Niacin—atherosclerosis	0.000727	0.0011	CcSEcCtD
Rasagiline—Headache—Simvastatin—atherosclerosis	0.000725	0.0011	CcSEcCtD
Rasagiline—CYP1A2—Estrogen Receptor Pathway—STAT3—atherosclerosis	0.000722	0.00213	CbGpPWpGaD
Rasagiline—Nausea—Ezetimibe—atherosclerosis	0.000721	0.00109	CcSEcCtD
Rasagiline—Diarrhoea—Pravastatin—atherosclerosis	0.000716	0.00108	CcSEcCtD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—NFKB1—atherosclerosis	0.000711	0.0021	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—APOE—atherosclerosis	0.000711	0.0021	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—CXCL8—atherosclerosis	0.000709	0.00209	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—NFKB1—atherosclerosis	0.000705	0.00208	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—FCGR3A—atherosclerosis	0.000704	0.00207	CbGpPWpGaD
Rasagiline—Dizziness—Niacin—atherosclerosis	0.000703	0.00106	CcSEcCtD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—MAPK8—atherosclerosis	0.000699	0.00206	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—PDGFB—atherosclerosis	0.000694	0.00205	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—MAPK8—atherosclerosis	0.000693	0.00204	CbGpPWpGaD
Rasagiline—Dizziness—Pravastatin—atherosclerosis	0.000692	0.00105	CcSEcCtD
Rasagiline—Nausea—Simvastatin—atherosclerosis	0.000687	0.00104	CcSEcCtD
Rasagiline—BCL2—Ceramide signaling pathway—AKT1—atherosclerosis	0.000687	0.00203	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL1B—atherosclerosis	0.00068	0.002	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—MMP2—atherosclerosis	0.000678	0.002	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—AKT1—atherosclerosis	0.000676	0.00199	CbGpPWpGaD
Rasagiline—Vomiting—Niacin—atherosclerosis	0.000675	0.00102	CcSEcCtD
Rasagiline—Rash—Niacin—atherosclerosis	0.00067	0.00101	CcSEcCtD
Rasagiline—Dermatitis—Niacin—atherosclerosis	0.000669	0.00101	CcSEcCtD
Rasagiline—Headache—Niacin—atherosclerosis	0.000666	0.00101	CcSEcCtD
Rasagiline—Vomiting—Pravastatin—atherosclerosis	0.000665	0.00101	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—SERPINE1—atherosclerosis	0.000665	0.00196	CbGpPWpGaD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.00066	0.00195	CbGpPWpGaD
Rasagiline—Rash—Pravastatin—atherosclerosis	0.00066	0.000998	CcSEcCtD
Rasagiline—Dermatitis—Pravastatin—atherosclerosis	0.000659	0.000997	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—CAV1—atherosclerosis	0.000658	0.00194	CbGpPWpGaD
Rasagiline—Headache—Pravastatin—atherosclerosis	0.000655	0.000992	CcSEcCtD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—AKT1—atherosclerosis	0.000655	0.00193	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LDLRAP1—atherosclerosis	0.000638	0.00188	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—IL6—atherosclerosis	0.000632	0.00186	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000631	0.00186	CbGpPWpGaD
Rasagiline—Nausea—Niacin—atherosclerosis	0.000631	0.000955	CcSEcCtD
Rasagiline—Nausea—Pravastatin—atherosclerosis	0.000621	0.00094	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—NFKB1—atherosclerosis	0.000616	0.00181	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—MAPK3—atherosclerosis	0.000611	0.0018	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—MAPK3—atherosclerosis	0.000605	0.00178	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—MAPK8—atherosclerosis	0.000605	0.00178	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PLTP—atherosclerosis	0.0006	0.00177	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—PIK3CG—atherosclerosis	0.000599	0.00177	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—AKT1—atherosclerosis	0.000599	0.00176	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—atherosclerosis	0.00059	0.00174	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—TGFB1—atherosclerosis	0.000587	0.00173	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—LPL—atherosclerosis	0.000587	0.00173	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—AKT1—atherosclerosis	0.000583	0.00172	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	0.000558	0.00164	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—IGF1—atherosclerosis	0.000549	0.00162	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000546	0.00161	CbGpPWpGaD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000546	0.00161	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—GPX1—atherosclerosis	0.000536	0.00158	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TGFB1—atherosclerosis	0.000528	0.00156	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ABCG8—atherosclerosis	0.00052	0.00153	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LTA4H—atherosclerosis	0.00052	0.00153	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TGFB1—atherosclerosis	0.000513	0.00151	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP7A1—atherosclerosis	0.000504	0.00149	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000497	0.00147	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	0.000474	0.0014	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—atherosclerosis	0.00047	0.00138	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP27A1—atherosclerosis	0.000466	0.00137	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CCR2—atherosclerosis	0.000466	0.00137	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP27A1—atherosclerosis	0.00046	0.00135	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—MAPK8—atherosclerosis	0.000457	0.00135	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000453	0.00133	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—atherosclerosis	0.000439	0.00129	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TLR2—atherosclerosis	0.000433	0.00128	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	0.000431	0.00127	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.000423	0.00125	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ABCG1—atherosclerosis	0.000411	0.00121	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FCGR3A—atherosclerosis	0.00041	0.00121	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—AKT1—atherosclerosis	0.000408	0.0012	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL6—atherosclerosis	0.000398	0.00117	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000393	0.00116	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD14—atherosclerosis	0.00039	0.00115	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—MAPK8—atherosclerosis	0.000388	0.00114	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000386	0.00114	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LCAT—atherosclerosis	0.000386	0.00114	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—FABP4—atherosclerosis	0.000386	0.00114	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOA4—atherosclerosis	0.000379	0.00112	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP7A1—atherosclerosis	0.000373	0.0011	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—atherosclerosis	0.000361	0.00106	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—VEGFA—atherosclerosis	0.000358	0.00106	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000357	0.00105	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—AKT1—atherosclerosis	0.000357	0.00105	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTM1—atherosclerosis	0.000356	0.00105	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.000352	0.00104	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP27A1—atherosclerosis	0.000344	0.00101	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000338	0.000995	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	0.000337	0.000993	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000331	0.000976	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000327	0.000965	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALOX5AP—atherosclerosis	0.000326	0.000962	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PLA2G2A—atherosclerosis	0.000326	0.000962	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALOX15—atherosclerosis	0.000326	0.000962	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOA2—atherosclerosis	0.000326	0.000962	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ABCG5—atherosclerosis	0.000322	0.00095	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AGER—atherosclerosis	0.00032	0.000943	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PRKCG—atherosclerosis	0.000317	0.000933	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.000315	0.000929	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.000314	0.000924	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000312	0.000918	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LPA—atherosclerosis	0.000311	0.000918	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD36—atherosclerosis	0.000309	0.000912	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000306	0.000901	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—BGN—atherosclerosis	0.000302	0.000889	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOA5—atherosclerosis	0.000299	0.00088	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000292	0.000862	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PLA2G1B—atherosclerosis	0.000287	0.000847	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NCF1—atherosclerosis	0.000287	0.000846	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PDGFB—atherosclerosis	0.000285	0.000841	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CRP—atherosclerosis	0.000279	0.000822	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALOX5—atherosclerosis	0.000278	0.000818	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	0.000275	0.00081	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CCR2—atherosclerosis	0.000271	0.000799	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00027	0.000796	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00027	0.000796	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CYBA—atherosclerosis	0.00027	0.000796	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—atherosclerosis	0.000269	0.000793	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TLR4—atherosclerosis	0.000267	0.000788	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000265	0.000782	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD40—atherosclerosis	0.000252	0.000743	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TLR2—atherosclerosis	0.000252	0.000743	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NAMPT—atherosclerosis	0.000249	0.000734	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LIPC—atherosclerosis	0.000247	0.000729	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOC3—atherosclerosis	0.000246	0.000724	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LDLR—atherosclerosis	0.000244	0.00072	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000244	0.000718	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CETP—atherosclerosis	0.000239	0.000703	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—AKT1—atherosclerosis	0.000229	0.000674	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SCARB1—atherosclerosis	0.000229	0.000674	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.000228	0.000671	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.000228	0.00067	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000228	0.00067	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD14—atherosclerosis	0.000227	0.00067	CbGpPWpGaD
Rasagiline—BCL2—Immune System—VCAM1—atherosclerosis	0.000219	0.000646	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HMGCR—atherosclerosis	0.000216	0.000636	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000214	0.000629	CbGpPWpGaD
Rasagiline—BCL2—Immune System—SOCS3—atherosclerosis	0.000213	0.000627	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	0.000208	0.000613	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	0.000205	0.000605	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000201	0.000592	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000201	0.000592	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000197	0.000581	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL18—atherosclerosis	0.000194	0.000572	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000194	0.00057	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD40LG—atherosclerosis	0.000193	0.000569	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ABCA1—atherosclerosis	0.000192	0.000567	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AGER—atherosclerosis	0.000186	0.000549	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PRKCG—atherosclerosis	0.000184	0.000543	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD36—atherosclerosis	0.00018	0.000531	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000179	0.000527	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.00017	0.0005	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.00017	0.0005	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.00017	0.0005	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.00017	0.0005	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000168	0.000494	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PDGFB—atherosclerosis	0.000166	0.00049	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HMOX1—atherosclerosis	0.000165	0.000486	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CRP—atherosclerosis	0.000162	0.000479	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—NFKB1—atherosclerosis	0.000162	0.000478	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000162	0.000477	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAPK8—atherosclerosis	0.00016	0.00047	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOB—atherosclerosis	0.000158	0.000466	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TLR4—atherosclerosis	0.000156	0.000459	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000155	0.000457	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTM1—atherosclerosis	0.000154	0.000453	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LPL—atherosclerosis	0.000151	0.000445	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000149	0.00044	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ICAM1—atherosclerosis	0.000149	0.00044	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	0.000148	0.000435	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GPX1—atherosclerosis	0.000147	0.000434	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000144	0.000425	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CD36—atherosclerosis	0.000143	0.000423	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAPK3—atherosclerosis	0.000139	0.000411	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLTP—atherosclerosis	0.000139	0.000409	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—MTHFR—atherosclerosis	0.000136	0.000401	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPARA—atherosclerosis	0.000133	0.000393	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AGT—atherosclerosis	0.000129	0.000381	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000129	0.000379	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000128	0.000376	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000127	0.000374	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOE—atherosclerosis	0.000127	0.000373	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CAV1—atherosclerosis	0.000125	0.000369	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOA1—atherosclerosis	0.000125	0.000369	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000124	0.000365	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCG8—atherosclerosis	0.00012	0.000354	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LTA4H—atherosclerosis	0.00012	0.000354	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000119	0.00035	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PIK3CG—atherosclerosis	0.000114	0.000337	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IFNG—atherosclerosis	0.000114	0.000335	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000112	0.000331	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPARG—atherosclerosis	0.00011	0.000325	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—INS—atherosclerosis	0.000108	0.000319	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6—atherosclerosis	0.000102	0.0003	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1B—atherosclerosis	0.000101	0.000299	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.0001	0.000295	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALB—atherosclerosis	9.91e-05	0.000292	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCG1—atherosclerosis	9.51e-05	0.00028	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NOS3—atherosclerosis	9.48e-05	0.000279	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NFKB1—atherosclerosis	9.45e-05	0.000279	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AKT1—atherosclerosis	9.4e-05	0.000277	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAPK8—atherosclerosis	9.29e-05	0.000274	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—FABP4—atherosclerosis	8.94e-05	0.000263	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LCAT—atherosclerosis	8.94e-05	0.000263	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOA4—atherosclerosis	8.78e-05	0.000259	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS2—atherosclerosis	8.67e-05	0.000256	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP7A1—atherosclerosis	8.62e-05	0.000254	CbGpPWpGaD
Rasagiline—BCL2—Immune System—STAT3—atherosclerosis	8.5e-05	0.00025	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	8.22e-05	0.000242	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAPK3—atherosclerosis	8.12e-05	0.000239	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP27A1—atherosclerosis	7.97e-05	0.000235	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.84e-05	0.000231	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	7.65e-05	0.000226	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOA2—atherosclerosis	7.55e-05	0.000223	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	7.55e-05	0.000223	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	7.55e-05	0.000223	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALOX15—atherosclerosis	7.55e-05	0.000223	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCG5—atherosclerosis	7.46e-05	0.00022	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	7.45e-05	0.00022	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LPA—atherosclerosis	7.21e-05	0.000212	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—BGN—atherosclerosis	6.98e-05	0.000206	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.93e-05	0.000204	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOA5—atherosclerosis	6.91e-05	0.000204	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.71e-05	0.000198	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	6.65e-05	0.000196	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.58e-05	0.000194	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.52e-05	0.000192	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.5e-05	0.000192	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALOX5—atherosclerosis	6.42e-05	0.000189	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6—atherosclerosis	5.93e-05	0.000175	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.93e-05	0.000175	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NAMPT—atherosclerosis	5.76e-05	0.00017	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.73e-05	0.000169	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LIPC—atherosclerosis	5.72e-05	0.000169	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOC3—atherosclerosis	5.69e-05	0.000168	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LDLR—atherosclerosis	5.65e-05	0.000167	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CETP—atherosclerosis	5.52e-05	0.000163	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AKT1—atherosclerosis	5.48e-05	0.000161	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SCARB1—atherosclerosis	5.29e-05	0.000156	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.15e-05	0.000152	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HMGCR—atherosclerosis	5e-05	0.000147	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.51e-05	0.000133	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCA1—atherosclerosis	4.45e-05	0.000131	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKT1—atherosclerosis	4.36e-05	0.000128	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.82e-05	0.000113	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOB—atherosclerosis	3.66e-05	0.000108	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.56e-05	0.000105	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LPL—atherosclerosis	3.49e-05	0.000103	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GPX1—atherosclerosis	3.41e-05	0.0001	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CD36—atherosclerosis	3.32e-05	9.78e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.15e-05	9.27e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPARA—atherosclerosis	3.09e-05	9.09e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AGT—atherosclerosis	2.99e-05	8.81e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOE—atherosclerosis	2.93e-05	8.63e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CAV1—atherosclerosis	2.9e-05	8.55e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOA1—atherosclerosis	2.89e-05	8.53e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.64e-05	7.79e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPARG—atherosclerosis	2.55e-05	7.52e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—INS—atherosclerosis	2.5e-05	7.37e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALB—atherosclerosis	2.29e-05	6.76e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NOS3—atherosclerosis	2.19e-05	6.47e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.01e-05	5.91e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKT1—atherosclerosis	1.01e-05	2.97e-05	CbGpPWpGaD
